Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 1,541,573 | 1,557,666 | 1,542,448 | 1,371,868 | 1,517,557 |
| Cost of Goods | 656,838 | 587,355 | 597,808 | 520,834 | 564,681 |
| Gross Profit | 884,735 | 970,311 | 944,640 | 851,034 | 952,876 |
| Operating Expenses | 774,047 | 731,746 | 748,218 | 700,498 | 859,797 |
| Operating Income | 111,526 | 238,920 | 197,230 | 151,370 | 93,760 |
| Interest Expense | 51,377 | 49,594 | 50,395 | 71,581 | 53,957 |
| Other Income | 20,920 | 24,568 | 67,842 | 13,731 | 20,301 |
| Pre-tax Income | 81,069 | 213,894 | 214,677 | 93,520 | 60,104 |
| Income Tax | 13,328 | 33,344 | 45,602 | -40,372 | 9,903 |
| Net Income Continuous | 67,741 | 180,550 | 169,075 | 133,892 | 50,201 |
| Net Income | $67,741 | $180,550 | $169,075 | $133,892 | $50,201 |
| EPS Basic Total Ops | 0.85 | 2.18 | 2.00 | 1.58 | 0.59 |
| EPS Basic Continuous Ops | 0.85 | 2.18 | 2.00 | 1.58 | 0.59 |
| EPS Diluted Total Ops | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 |
| EPS Diluted Continuous Ops | 0.84 | 2.16 | 1.98 | 1.57 | 0.58 |
| EPS Diluted Before Non-Recurring Items | 3.10 | 3.36 | 3.18 | 2.45 | 2.74 |
| EBITDA(a) | $241,202 | $364,064 | $324,096 | $294,892 | $208,612 |